Search - tctmd.com

Displaying 21 - 40 of 43

Sort: Relevancy | Date

Presentation TCT 2023

TCT 775: A Machine Learning Based Model Predicts Death in Patients with Severe Asymptomatic Aortic Stenosis

Presenter: APURVA BHARUCHA

October 26, 2023

Presentation TCT 2023

TCT 331: Cardiac Damage Staging Predicts Outcomes in Symptomatic and Asymptomatic Aortic Valve Stenosis after Aortic Valve Replacement: Meta-Analysis of Reconstructed Time-to-Event Data

Presenter: Omar Abdelfattah

October 26, 2023

Presentation TCT 2022

Case Presentation: A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis

Presenter: Tom Cahill

September 18, 2022

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

Presenter: Philippe Genereux

October 16, 2020

Presentation Live Valves 2019

Asymptomatic AS Live Valves-2019

Presenter: Maurice E. Sarano

December 10, 2019

Presentation

Outcomes of Patients with Asymptomatic Aortic Stenosis (AS) Followed Up in Heart Valve Clinics

October 03, 2018

Presentation TCT 2018

Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis

Presenter: Philippe Genereux

September 22, 2018

Presentation TCT 2018

Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization

Presenter: Eric Van Belle

September 22, 2018

Presentation TCT 2018

Who Should be Treated? The Role of Imaging Guidance in Patient Selection

Presenter: Philippe Pibarot

September 22, 2018

Presentation TCT 2018

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

Presenter: Allan Schwartz

September 22, 2018

Presentation ECHO 2018

The Role of Echo in the Management of Asymptomatic VHD

Presenter: Philippe Pibarot

April 18, 2018

Presentation TCT 2017

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Presenter: Ariel Finkelstein, Ran Kornowski, Philippe Genereux

November 01, 2017

Presentation TCT 2017

Asymptomatic Severe Aortic Stenosis: To Treat or to Watch?

Presenter: Bernard Prendergast, Brian K. Whisenant, Allan Schwartz

November 01, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Expanding TAVR Indications (Heart Failure, Asymptomatic Severe AS, and Aortic Regurgitation)

Presenter: Jeroen J. Bax, Axel Linke, Nicolas M. Van Mieghem

October 29, 2017

Presentation TVT 2017

Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: David J. Cohen, Jeffrey J. Popma, Philippe Généreux

June 16, 2017

Presentation ECHO 2017

The Role of Echo in the Management of Asymptomatic Disease

Presenter: Philippe Pibarot

April 01, 2017

Presentation TCT 2015

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Presenter: John D. Carroll, Ioanna Kosmidou, Tomohiko Taniguchi

October 15, 2015

Presentation TCT 2015

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Presenter: Tomohiko Taniguchi

October 15, 2015

Presentation TCT 2015

Severe Asymptomatic Aortic Stenosis: Thoughtful Commentary on the Case

Presenter: Robert O. Bonow, Allan Schwartz

October 12, 2015

Advertisement

TCT 775: A Machine Learning Based Model Predicts Death in Patients with Severe Asymptomatic Aortic Stenosis

TCT 331: Cardiac Damage Staging Predicts Outcomes in Symptomatic and Asymptomatic Aortic Valve Stenosis after Aortic Valve Replacement: Meta-Analysis of Reconstructed Time-to-Event Data

Case Presentation: A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis

TAVR in Low Surgical Risk Patients - Intervention (Surgery or TAVR) in Severe Asymptomatic Aortic Stenosis: Evidence Updates

Asymptomatic AS Live Valves-2019

Outcomes of Patients with Asymptomatic Aortic Stenosis (AS) Followed Up in Heart Valve Clinics

Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis

Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization

Who Should be Treated? The Role of Imaging Guidance in Patient Selection

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

The Role of Echo in the Management of Asymptomatic VHD

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Asymptomatic Severe Aortic Stenosis: To Treat or to Watch?

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Expanding TAVR Indications (Heart Failure, Asymptomatic Severe AS, and Aortic Regurgitation)

Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

The Role of Echo in the Management of Asymptomatic Disease

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Evaluation of Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis

Severe Asymptomatic Aortic Stenosis: Thoughtful Commentary on the Case

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content